Assessment of Acute and Chronic Pharmacological Effects on Energy Expenditure and Macronutrient Oxidation in Humans: Responses to Ephedrine
Table 4
(a) Differences between ephedrine- and placebo-related changes in overnight macronutrient oxidation and energy expenditure, between treated (days 1 and 14) and untreated (day 0), and between chronic and acute treatments (days 14 and 1)
Interval
Protein
Carbohydrate
Fat
Energy
days
difference (kJ)
difference (kJ)
difference (kJ)
difference (kJ)
1-0
46.7
.75
41.4
.86
150.8
.14
62.7
.05
14–0
95.9
.32
10.8
.98
190.3
.05
105.2
.001
14–1
46.2
.73
52.2
.78
39.5
.86
42.5
.23
(b) Differences between ephedrine and placebo treatment effects on changes in macronutrient oxidation and energy expenditure over 23 h, from 22:00 to 21:00, between treated (days 1 and 14) and untreated (day 0), and between chronic and acute treatments (days 14 and 1)
